People / Staff

Cinzia Emilia Lavarino

Search publications

Publications

  • Rabadán MA, Usieto S, Lavarino C and Martí E.

    Identification of a Putative Transcriptome Signature Common to Neuroblastoma and Neural Crest Cells

    DEVELOPMENTAL NEUROBIOLOGY . 73(11): 815-827. Number of citations: 12

    [doi:10.1002/dneu.22099]

  • Masvidal L, Iniesta R, Casalà C, Galván P, Rodriguez E, Lavarino C, Mora J and de Torres C.

    Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma

    PLoS One . 8(3): . Number of citations: 13

    [doi:10.1371/journal.pone.0059762]

  • Casalà C, Gil-Guiñón E, Ordóñez JL, Miguel-Queralt S, Rodriguez E, Galván P, Lavarino C, Munell F, de Alava E, Mora J and de Torres C.

    The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis

    Carcinogenesis . 34(2): 268-276. Number of citations: 36

    [doi:10.1093/carcin/bgs338]

  • Mayol G, Martín-Subero JI, Ríos J, Queiros A, Kulis M, Suñol M, Esteller M, Gomez-Gonzalez S, Garcia I, de Torres C, Rodriguez E, Galván P, Mora J and Lavarino C.

    DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis

    PLoS One . 7(11): . Number of citations: 33

    [doi:10.1371/journal.pone.0048401]

  • Morales-La Madrid A, Volchenboum S, Gastier-Foster JM, Pyatt R, Liu D, Pytel P, Lavarino C, Rodriguez E and Cohn SL.

    Locoregional MYCN-amplified neuroblastoma

    PEDIATRIC BLOOD & CANCER . 59(4): 736-738.

    [doi:10.1002/pbc.24003]

  • Garcia I, Mayol G, Ríos J, Domenech G, Cheung NK, Oberthuer A, Fischer M, Maris JM, Brodeur GM, Hero B, Rodriguez E, Suñol M, Galvan P, de Torres C, Mora J and Lavarino C.

    A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

    CLINICAL CANCER RESEARCH . 18(7): 2012-2023. Number of citations: 55

    [doi:10.1158/1078-0432.CCR-11-2483]

  • Acosta S, Mayol G, Rodriguez E, Lavarino C, de Preter K, Kumps C, Garcia I, de Torres C and Mora J.

    Identification of tumoral glial precursor cells in neuroblastoma

    CANCER LETTERS . 312(1): 73-81. Number of citations: 12

    [doi:10.1016/j.canlet.2011.08.004]

  • Garcia I, Mayol G, Rodriguez E, Suñol M, Gershon TR, Ríos J, Cheung NK, Kieran MW, George RE, Perez-Atayde AR, Casalà C, Galván P, de Torres C, Mora J and Lavarino C.

    Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma

    MOLECULAR CANCER . 9: 277-277. Number of citations: 58

    [doi:10.1186/1476-4598-9-277]

  • De Preter K, Vermeulen J, Brors B, Delattre O, Eggert A, Fischer M, Janoueix-Lerosey I, Lavarino C, Maris JM, Mora J, Nakagawara A, Oberthuer A, Ohira M, Schleiermacher G, Schramm A, Schulte JH, Wang Q, Westermann F, Speleman F and Vandesompele J.

    Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

    CLINICAL CANCER RESEARCH . 16(5): 1532-1541. Number of citations: 76

    [doi:10.1158/1078-0432.CCR-09-2607]

  • de Torres C, Beleta H, Díaz-Naderi R, Toran N, Rodríguez E, Lavarino C, García I, Acosta S, Suñol M and Mora J.

    The Calcium-Sensing Receptor and Parathyroid Hormone-related Protein Are Expressed in Differentiated, Favorable Neuroblastic Tumors

    CANCER . 115(12): 2792-2803. Number of citations: 24

    [doi:10.1002/cncr.24304]